Projected Stock Price
No data available.
Projected Revenue
No data available.
Projected Earnings Per Share
Estimated quarterly earnings by December 31, 2026.
Price Target
No data available.
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for M&T Bank Corporation. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
In addition to being able to interpret financial data, stock analysts have connections within the companies they cover that give them access to information retail investors do not have.
Therefore, analyst ratings can help you find opportunities in the market. However, they are guidelines more than recommendations. This is why it’s important to look at analyst ratings over a period of time.
If analysts change their ratings frequently, you should pay close attention to the company’s fundamentals. For example, has there been a significant change to the company’s earnings growth and/or debt?
You should also pay attention to the number of analysts covering a stock over the course of a year. In general, the more analysts who cover the stock give the consensus rating more credibility, but each individual rating less overall weight.
Analyst ratings are one data point for you to consider. Here are some strategies you can use to fine tune your research.
Look at more than one analyst and don’t hesitate to look at analysts that have differing views. This can help challenge any preconceived ideas you have about a stock and point out ways in which your thesis for owning or avoiding a stock may have changed.
Compare a stock’s rating with other stocks in its industry or sector. In some cases, a stock is simply superior to others in its sector. However, at other times, it could be overvalued based on investor sentiment instead of fundamentals.
How are the Fintel Analyst Ratings different?Analyst ratings by Fintel are presented in close to real-time to stay ahead of generalized information flow. Combined with target price estimates and revenue estimates for the company you have greater accuracy despite market volatility.
Date | Analyst | Prior | Latest Recommendation |
Action |
---|---|---|---|---|
2025-04-03 | JP Morgan | Neutral | Neutral | Maintains |
2025-03-28 | Wells Fargo | Underweight | Underweight | Maintains |
2025-03-13 | Evercore ISI Group | Outperform | Outperform | Maintains |
2025-03-13 | Morgan Stanley | Overweight | Overweight | Maintains |
2025-01-17 | Truist Securities | Buy | Buy | Reiterate |
2025-01-17 | DA Davidson | Neutral | Neutral | Maintains |
2025-01-07 | Truist Securities | Buy | Initiate | |
2025-01-06 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2024-12-10 | Compass Point | Neutral | Neutral | Maintains |
2024-12-04 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
2024-12-04 | JP Morgan | Overweight | Neutral | Downgrade |
2024-11-27 | Piper Sandler | Overweight | Overweight | Maintains |
2024-11-26 | Goldman Sachs | Neutral | Neutral | Maintains |
2024-11-25 | Citigroup | Buy | Neutral | Downgrade |
2024-11-15 | Wells Fargo | Underweight | Underweight | Maintains |
2024-10-30 | Evercore ISI Group | Outperform | Outperform | Maintains |
2024-10-21 | DA Davidson | Neutral | Neutral | Maintains |
2024-10-18 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2024-10-18 | Goldman Sachs | Neutral | Neutral | Maintains |
2024-10-18 | B of A Securities | Buy | Buy | Maintains |
2024-10-18 | Wells Fargo | Underweight | Underweight | Maintains |
2024-10-18 | RBC Capital | Outperform | Outperform | Maintains |
2024-10-04 | Wolfe Research | Peer Perform | Outperform | Upgrade |
2024-10-02 | Evercore ISI Group | In-Line | Outperform | Upgrade |
2024-09-24 | Wedbush | Outperform | Outperform | Maintains |
2024-09-03 | JP Morgan | Neutral | Overweight | Upgrade |
2024-08-15 | Wells Fargo | Equal-Weight | Underweight | Downgrade |
2024-08-05 | Morgan Stanley | Overweight | Overweight | Maintains |
2024-07-23 | JP Morgan | Neutral | Neutral | Maintains |
2024-07-22 | B of A Securities | Buy | Buy | Maintains |
2024-07-22 | Piper Sandler | Overweight | Overweight | Maintains |
2024-07-19 | Citigroup | Buy | Buy | Maintains |
2024-07-19 | DA Davidson | Neutral | Neutral | Maintains |
2024-07-19 | RBC Capital | Outperform | Outperform | Maintains |
2024-07-19 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
2024-07-03 | Jefferies | Hold | Hold | Maintains |
2024-06-27 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
2024-06-25 | Evercore ISI Group | In-Line | In-Line | Maintains |
2024-06-21 | Piper Sandler | Overweight | Overweight | Maintains |
2024-06-12 | Piper Sandler | Overweight | Overweight | Maintains |
2024-06-04 | Jefferies | Hold | Hold | Maintains |
2024-04-16 | DA Davidson | Neutral | Neutral | Maintains |
2024-04-16 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
2024-04-16 | JP Morgan | Neutral | Neutral | Maintains |
2024-04-16 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
2024-04-16 | RBC Capital | Outperform | Outperform | Reiterate |
2024-04-16 | B of A Securities | Buy | Buy | Maintains |
2024-04-10 | Wedbush | Outperform | Outperform | Reiterate |
2024-04-08 | Jefferies | Hold | Hold | Maintains |
2024-04-05 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
2024-04-04 | JP Morgan | Neutral | Neutral | Maintains |
2024-03-28 | Evercore ISI Group | In-Line | In-Line | Maintains |
2024-03-06 | DA Davidson | Neutral | Neutral | Reiterate |
2024-02-07 | Morgan Stanley | Overweight | Overweight | Maintains |
2024-01-19 | Piper Sandler | Overweight | Overweight | Maintains |
2024-01-19 | DA Davidson | Neutral | Neutral | Maintains |
2024-01-19 | RBC Capital | Outperform | Outperform | Reiterate |
2024-01-02 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2023-12-18 | Deutsche Bank | Buy | Hold | Downgrade |
2023-12-04 | Morgan Stanley | Overweight | Overweight | Maintains |
2023-10-19 | Wedbush | Outperform | Outperform | Maintains |
2023-09-29 | Odeon Capital | Buy | Hold | Downgrade |
2023-09-27 | Morgan Stanley | Overweight | Overweight | Maintains |
2023-09-11 | RBC Capital | Outperform | Outperform | Maintains |
2023-07-21 | Morgan Stanley | Overweight | Overweight | Reiterate |
2023-07-20 | Wedbush | Outperform | Outperform | Maintains |
2023-07-07 | Morgan Stanley | Overweight | Overweight | Reiterate |
2023-06-15 | Morgan Stanley | Overweight | Reiterate | |
2023-06-15 | RBC Capital | Outperform | Outperform | Reiterate |
2023-06-14 | DA Davidson | Neutral | Maintains | |
2023-06-09 | Citigroup | Buy | Reiterate | |
2023-05-16 | Morgan Stanley | Overweight | Overweight | Maintains |
2023-04-18 | DA Davidson | Neutral | Maintains | |
2023-04-18 | Argus Research | Hold | Buy | Upgrade |
2023-04-18 | B of A Securities | Buy | Maintains | |
2023-04-18 | JP Morgan | Neutral | Maintains | |
2023-04-18 | Wells Fargo | Equal-Weight | Maintains | |
2023-04-10 | UBS | Buy | Neutral | Downgrade |
2023-04-05 | Morgan Stanley | Overweight | Maintains | |
2023-04-03 | Wells Fargo | Equal-Weight | Maintains | |
2023-03-27 | Citigroup | Neutral | Buy | Upgrade |
2023-03-24 | RBC Capital | Outperform | Maintains | |
2023-03-23 | Wolfe Research | Outperform | Peer Perform | Downgrade |
2023-02-22 | Citigroup | Neutral | Maintains | |
2023-01-23 | JP Morgan | Neutral | Maintains | |
2023-01-23 | Morgan Stanley | Overweight | Maintains | |
2023-01-10 | Odeon Capital | Hold | Buy | Upgrade |
2023-01-03 | Wedbush | Neutral | Outperform | Upgrade |
2023-01-03 | Barclays | Overweight | Equal-Weight | Downgrade |
2022-12-21 | DA Davidson | Neutral | Initiate | |
2022-12-16 | Morgan Stanley | Overweight | Maintains | |
2022-12-13 | JP Morgan | Neutral | Maintains | |
2022-12-08 | Wells Fargo | Equal-Weight | Maintains | |
2022-12-07 | Keefe, Bruyette & Woods | Outperform | Market Perform | Downgrade |
2022-12-05 | Morgan Stanley | Overweight | Maintains | |
2022-10-21 | Citigroup | Neutral | Maintains | |
2022-10-20 | Piper Sandler | Overweight | Maintains | |
2022-10-20 | Wedbush | Neutral | Maintains | |
2022-10-20 | Morgan Stanley | Overweight | Maintains | |
2022-10-20 | Barclays | Overweight | Maintains | |
2022-10-05 | Morgan Stanley | Overweight | Maintains | |
2022-10-04 | Citigroup | Buy | Neutral | Downgrade |
2022-09-12 | Deutsche Bank | Buy | Maintains | |
2022-07-21 | Morgan Stanley | Overweight | Maintains | |
2022-07-21 | Barclays | Overweight | Maintains | |
2022-07-12 | Morgan Stanley | Overweight | Maintains | |
2022-07-11 | Jefferies | Hold | Maintains | |
2022-07-01 | JP Morgan | Neutral | Maintains | |
2022-07-01 | Wells Fargo | Equal-Weight | Maintains | |
2022-06-17 | Baird | Neutral | Outperform | Upgrade |
2022-05-26 | Wolfe Research | Outperform | Maintains | |
2022-04-21 | Morgan Stanley | Underweight | Overweight | Upgrade |
2022-04-21 | Wells Fargo | Equal-Weight | Maintains | |
2022-04-04 | Goldman Sachs | Neutral | Maintains | |
2022-03-28 | Morgan Stanley | Equal-Weight | Underweight | Downgrade |
2022-03-07 | Wells Fargo | Equal-Weight | Maintains | |
2022-01-24 | Piper Sandler | Neutral | Overweight | Upgrade |
2022-01-21 | Morgan Stanley | Equal-Weight | Maintains | |
2022-01-13 | UBS | Buy | Initiate | |
2021-12-16 | Citigroup | Buy | Maintains | |
2021-12-06 | Morgan Stanley | Equal-Weight | Maintains | |
2021-10-27 | Morgan Stanley | Equal-Weight | Maintains | |
2021-10-25 | Citigroup | Buy | Maintains | |
2021-10-21 | Piper Sandler | Neutral | Maintains | |
2021-10-21 | RBC Capital | Outperform | Maintains | |
2021-10-11 | Jefferies | Hold | Maintains | |
2021-08-02 | Morgan Stanley | Equal-Weight | Maintains | |
2021-07-22 | Wedbush | Neutral | Maintains | |
2021-07-22 | Wells Fargo | Equal-Weight | Maintains | |
2021-04-29 | Morgan Stanley | Equal-Weight | Maintains | |
2021-04-01 | Deutsche Bank | Buy | Maintains | |
2021-03-18 | Morgan Stanley | Equal-Weight | Maintains | |
2021-02-24 | Morgan Stanley | Equal-Weight | Maintains | |
2021-02-23 | Wells Fargo | Equal-Weight | Maintains | |
2021-02-23 | RBC Capital | Outperform | Maintains | |
2021-01-28 | Deutsche Bank | Buy | Maintains | |
2021-01-26 | Morgan Stanley | Equal-Weight | Maintains | |
2021-01-07 | Morgan Stanley | Equal-Weight | Maintains | |
2021-01-07 | B of A Securities | Neutral | Buy | Upgrade |
2020-12-07 | Morgan Stanley | Equal-Weight | Maintains | |
2020-11-03 | Morgan Stanley | Equal-Weight | Maintains | |
2020-09-08 | Odeon Capital | Sell | Hold | Upgrade |
2020-08-04 | Morgan Stanley | Equal-Weight | Maintains | |
2020-06-08 | Morgan Stanley | Equal-Weight | Maintains | |
2020-05-13 | Compass Point | Neutral | Maintains | |
2020-05-06 | Morgan Stanley | Equal-Weight | Maintains | |
2020-05-04 | UBS | Neutral | Maintains | |
2020-04-21 | CFRA | Hold | Maintains | |
2020-04-07 | Nomura | Neutral | Maintains | |
2020-04-07 | Morgan Stanley | Equal-Weight | Maintains | |
2020-04-06 | UBS | Neutral | Maintains | |
2020-04-02 | Deutsche Bank | Buy | Maintains | |
2020-04-01 | Wells Fargo | Equal-Weight | Maintains | |
2020-03-27 | Citigroup | Neutral | Maintains | |
2020-03-17 | Morgan Stanley | Equal-Weight | Maintains | |
2020-03-09 | Morgan Stanley | Equal-Weight | Maintains | |
2020-03-05 | Morgan Stanley | Equal-Weight | Maintains | |
2020-01-28 | Morgan Stanley | Equal-Weight | Maintains | |
2020-01-24 | Odeon Capital | Hold | Buy | Upgrade |
2020-01-24 | Wedbush | Neutral | Maintains | |
2020-01-24 | B of A Securities | Underperform | Neutral | Upgrade |
2020-01-06 | Deutsche Bank | Hold | Buy | Upgrade |
2020-01-06 | Goldman Sachs | Buy | Neutral | Downgrade |
2019-12-16 | Citigroup | Neutral | Maintains | |
2019-12-12 | Morgan Stanley | Equal-Weight | Maintains | |
2019-10-24 | CFRA | Buy | Hold | Downgrade |
2019-10-21 | UBS | Neutral | Maintains | |
2019-10-21 | Evercore ISI Group | Outperform | In-Line | Downgrade |
2019-10-18 | Citigroup | Neutral | Maintains | |
2019-10-18 | Barclays | Overweight | Maintains | |
2019-10-18 | Wedbush | Neutral | Maintains | |
2019-10-18 | Keefe, Bruyette & Woods | Outperform | Market Perform | Downgrade |
2019-10-08 | Jefferies | Buy | Hold | Downgrade |
2019-10-08 | Citi | Sell | Neutral | Upgrade |
2019-10-03 | Morgan Stanley | Equal-Weight | Maintains | |
2019-09-27 | Odeon Capital | Hold | Initiate | |
2019-09-09 | Citigroup | Sell | Maintains | |
2019-07-22 | Piper Jaffray | Overweight | Neutral | Downgrade |
2019-07-19 | Barclays | Overweight | Maintains | |
2019-07-19 | Keefe Bruyette & Woods | Outperform | Maintains | |
2019-07-12 | Citi | Neutral | Sell | Downgrade |
2019-07-10 | UBS | Neutral | Maintains | |
2019-07-02 | JP Morgan | Neutral | Maintains | |
2019-04-16 | Wedbush | Neutral | Neutral | Maintains |
2019-04-05 | Barclays | Overweight | Overweight | Maintains |
2019-03-19 | Citigroup | Neutral | Neutral | Maintains |
2019-02-21 | Baird | Outperform | Neutral | Downgrade |
2019-01-09 | UBS | Sell | Neutral | Upgrade |
2019-01-08 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2018-10-23 | Baird | Neutral | Outperform | Upgrade |
2018-10-22 | PiperJaffray | Neutral | Overweight | Upgrade |
2018-10-18 | Nomura | Neutral | Neutral | Maintains |
2018-10-01 | Evercore ISI Group | In-Line | Outperform | Upgrade |
2018-09-26 | Goldman Sachs | Neutral | Buy | Upgrade |
2018-09-18 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2018-09-04 | Keefe Bruyette & Woods | Market Perform | Outperform | Upgrade |
2018-07-20 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2018-07-19 | Wedbush | Neutral | Neutral | Maintains |
2018-06-27 | Bernstein | Market Perform | Outperform | Upgrade |
2018-04-18 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2018-04-18 | Baird | Underperform | Neutral | Upgrade |
2018-04-17 | Wedbush | Neutral | Neutral | Maintains |
2018-02-26 | Barclays | Overweight | Overweight | Maintains |
2017-12-14 | Morgan Stanley | Equal-Weight | Maintains | |
2017-12-12 | UBS | Sell | Neutral | Upgrade |
2017-10-23 | Nomura | Neutral | Maintains | |
2017-10-10 | Citigroup | Neutral | Maintains | |
2017-10-09 | Citigroup | Neutral | Maintains | |
2017-09-28 | Nomura | Neutral | Maintains | |
2017-08-04 | Macquarie | Neutral | Underperform | Downgrade |
2017-07-11 | Jefferies | Hold | Buy | Upgrade |
2016-12-15 | Bank of America | Neutral | Underperform | Downgrade |
2016-11-30 | Deutsche Bank | Hold | Maintains | |
2016-10-07 | Wedbush | Neutral | Initiate | |
2016-09-23 | CLSA | Outperform | Maintains | |
2016-08-01 | Morgan Stanley | Equal-Weight | Maintains | |
2016-07-07 | JP Morgan | Neutral | Maintains | |
2016-07-07 | Nomura | Buy | Neutral | Downgrade |
2016-07-05 | PiperJaffray | Neutral | Initiate | |
2016-04-22 | Deutsche Bank | Buy | Hold | Downgrade |
2016-04-21 | Portales Partners | Outperform | Sector Perform | Downgrade |
2016-04-21 | Baird | Neutral | Underperform | Downgrade |
2016-04-05 | JP Morgan | Neutral | Maintains | |
2016-03-30 | PiperJaffray | Neutral | Initiate | |
2016-03-29 | Argus | Hold | Initiate | |
2016-03-29 | Argus Research | Hold | Initiate | |
2016-03-10 | Credit Suisse | Buy | Maintains | |
2016-02-11 | Nomura | Buy | Maintains | |
2016-01-26 | Deutsche Bank | Buy | Maintains | |
2016-01-21 | SunTrust Robinson Humphrey | Buy | Maintains | |
2016-01-21 | Macquarie | Neutral | Maintains | |
2016-01-20 | Keefe Bruyette & Woods | Market Perform | Maintains | |
2016-01-20 | Barclays | Overweight | Maintains | |
2016-01-11 | Goldman Sachs | Buy | Neutral | Downgrade |
2015-11-02 | Evercore ISI Group | Hold | Initiate | |
2015-10-21 | Citigroup | Neutral | Maintains | |
2015-10-21 | Keefe Bruyette & Woods | Outperform | Market Perform | Downgrade |
2015-10-20 | Barclays | Overweight | Maintains | |
2015-10-08 | Sterne Agee CRT | Neutral | Maintains | |
2015-10-01 | Keefe Bruyette & Woods | Outperform | Maintains | |
2015-07-20 | RBC Capital | Outperform | Maintains | |
2015-06-29 | SunTrust Robinson Humphrey | Buy | Maintains | |
2015-06-23 | Wells Fargo | Underperform | Market Perform | Upgrade |
2015-04-27 | Citigroup | Neutral | Maintains | |
2015-04-22 | Keefe Bruyette & Woods | Outperform | Maintains | |
2015-04-21 | Barclays | Overweight | Maintains | |
2015-04-13 | Wells Fargo | Market Perform | Underperform | Downgrade |
2015-01-21 | Keefe Bruyette & Woods | Outperform | Maintains | |
2015-01-05 | Barclays | Overweight | Maintains | |
2014-12-10 | Raymond James | Market Perform | Underperform | Downgrade |
2014-10-23 | Citigroup | Neutral | Maintains | |
2014-07-21 | Keefe, Bruyette & Woods | Market Perform | Outperform | Upgrade |
2014-05-14 | Nomura | Buy | Initiate | |
2014-05-12 | Baird | Neutral | Neutral | Maintains |
2014-05-12 | Barclays | Overweight | Overweight | Maintains |
2014-05-12 | Goldman Sachs | Neutral | Buy | Upgrade |
2014-05-12 | Jefferies | Hold | Maintains | |
2014-04-24 | Deutsche Bank | Hold | Buy | Upgrade |
2014-04-07 | Citigroup | Neutral | Maintains | |
2014-03-07 | Rafferty | Sell | Hold | Upgrade |
2014-01-21 | Raymond James | Outperform | Market Perform | Downgrade |
2014-01-06 | Barclays | Equal-weight | Overweight | Upgrade |
2013-10-18 | Macquarie | Outperform | Neutral | Downgrade |
2013-10-07 | ISI Group | Buy | Initiate | |
2013-09-06 | Credit Suisse | Outperform | Neutral | Downgrade |
2013-08-02 | FBR Capital | Market Perform | Maintains | |
2013-07-18 | Sandler O'Neill | Buy | Hold | Downgrade |
2013-06-26 | Macquarie | Neutral | Outperform | Upgrade |
2013-06-14 | Sterne Agee | Neutral | Buy | Upgrade |
2013-06-06 | SunTrust Robinson Humphrey | Buy | Neutral | Downgrade |
2013-04-17 | Keefe Bruyette & Woods | Outperform | Market Perform | Downgrade |
2013-04-16 | Jefferies | Hold | Maintains | |
2013-04-03 | Citigroup | Neutral | Maintains | |
2013-03-18 | Raymond James | Market Perform | Outperform | Upgrade |
2013-02-27 | Rafferty Capital | Sell | Initiate | |
2013-01-17 | Credit Suisse | Outperform | Maintains | |
2013-01-08 | Citigroup | Neutral | Maintains | |
2013-01-04 | Deutsche Bank | Hold | Maintains | |
2012-12-19 | Goldman Sachs | Neutral | Initiate | |
2012-12-14 | Keefe Bruyette & Woods | Market Perform | Outperform | Upgrade |
2012-10-19 | Sterne Agee | Neutral | Maintains | |
2012-10-18 | Barclays | Equal-Weight | Maintains | |
2012-10-18 | Jefferies | Hold | Maintains | |
2012-10-10 | Credit Suisse | Neutral | Outperform | Upgrade |
2012-09-28 | Citigroup | Neutral | Maintains | |
2012-09-20 | Deutsche Bank | Hold | Maintains | |
2012-08-29 | Citigroup | Neutral | Maintains | |
2012-08-28 | Credit Suisse | Neutral | Maintains | |
2012-08-28 | Barclays | Equal-Weight | Maintains | |
2012-08-28 | Jefferies | Hold | Maintains | |
2012-07-18 | Jefferies | Hold | Maintains | |
2012-07-18 | Credit Suisse | Neutral | Maintains | |
2012-06-07 | Citigroup | Neutral | Maintains | |
2012-05-21 | Guggenheim | Neutral | Maintains | |
2012-04-17 | JP Morgan | Neutral | Maintains | |
2012-04-17 | Jefferies | Hold | Maintains | |
2012-04-17 | Bank oferica | Neutral | Maintains | |
2012-04-17 | Credit Suisse | Neutral | Maintains | |
2012-04-10 | Citigroup | Neutral | Maintains | |
2025-04-04 | Truist Securities | Buy | Buy | Maintains |
2025-03-24 | Citigroup | Neutral | Neutral | Maintains |
2025-04-15 | RBC Capital | Outperform | Outperform | Maintains |
2025-04-15 | Truist Securities | Buy | Buy | Maintains |
2025-04-15 | Piper Sandler | Overweight | Overweight | Maintains |
2025-04-15 | Wells Fargo | Underweight | Underweight | Maintains |
2025-04-15 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2025-04-15 | DA Davidson | Neutral | Neutral | Maintains |
2025-04-15 | Baird | Outperform | Outperform | Maintains |
2025-07-02 | Citigroup | Neutral | Neutral | Maintains |
2025-05-19 | RBC Capital | Outperform | Outperform | Reiterate |
2025-07-17 | Wells Fargo | Underweight | Underweight | Maintains |
2025-07-17 | DA Davidson | Neutral | Neutral | Maintains |
2025-06-20 | Morgan Stanley | Overweight | Overweight | Maintains |
2025-05-21 | Jefferies | Buy | Initiate | |
2025-06-23 | Citigroup | Neutral | Neutral | Maintains |
2025-09-03 | Jefferies | Buy | Buy | Maintains |
Revenue Estimates
No data available.
Earnings Estimates
The forecasted annual earnings of M&T Bank Corporation in 2032-12-31 is 15.94 per share.
One part of an analyst’s rating is a profit (i.e., earnings) estimate for the current quarter and/or future quarters. The measurement given is earnings per share (EPS). EPS is a metric that indicates how much a company earned as represented by one share of its stock over a specific period (typically three months).
To understand the earnings per share calculation, you must understand net income. Net income is the amount of money a company has left over after deducting appropriate expenses and taxes from its revenues).
The formula for earnings per share is net income divided by the total number of outstanding shares (i.e., available for purchase). For example:
Company A has a net income of $100 million and forty million outstanding shares. The EPS calculation is as follows:
100,000,000/40,000,000 = $2.50 per share
Earnings per share is an essential metric for you to consider when deciding to buy a stock. After all, a company with high earnings per share is productive and generates revenue in excess of its operating costs.
However, it’s not the only metric you should use. Metrics like price-to-earnings and debt-to-equity add additional perspective about a company’s health.
You should also be sure to compare a company’s EPS with a company in its sector. However, when you do, be aware that EPS is different and more important than net profit by itself. You may see a company that has a rising net profit. But if its outstanding shares are also rising, then its EPS might be flat or even edging lower.
Update Frequency: Quarterly
Date | EPS Average (Quarterly) | Number of Analysts (Quarterly) | EPS Average (Annual) | Number of Analysts (Annually) |
---|---|---|---|---|
2025-09-30 | 4.39 | 20 | -- | -- |
2025-12-31 | 4.57 | 20 | 16.53 | 22 |
2026-03-31 | 4.08 | 11 | -- | -- |
2026-06-30 | 4.78 | 11 | -- | -- |
2026-09-30 | 5.05 | 11 | -- | -- |
2026-12-31 | 5.20 | 11 | 18.88 | 21 |
2027-12-31 | -- | -- | 20.86 | 6 |
2028-12-31 | -- | -- | 15.31 | 2 |
2029-12-31 | -- | -- | 15.57 | 2 |
2030-12-31 | -- | -- | 15.83 | 2 |
2031-12-31 | -- | -- | 16.07 | 2 |
2032-12-31 | -- | -- | 15.94 | 2 |